Northwestern Mutual Wealth Management Co. Makes New Investment in Humana Inc. $HUM

Northwestern Mutual Wealth Management Co. bought a new stake in Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 2,824 shares of the insurance provider’s stock, valued at approximately $1,122,000.

Other hedge funds have also made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Humana by 4.1% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after purchasing an additional 9,960 shares during the period. Sustainable Insight Capital Management LLC increased its position in shares of Humana by 23.7% during the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after purchasing an additional 4,740 shares during the last quarter. Pzena Investment Management LLC purchased a new stake in Humana in the 2nd quarter valued at about $1,749,014,000. Swedbank AB raised its holdings in Humana by 6.2% in the 4th quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock valued at $28,636,000 after buying an additional 6,534 shares during the period. Finally, North Dakota State Investment Board acquired a new position in Humana in the fourth quarter valued at about $1,517,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE HUM opened at $388.92 on Wednesday. The company has a market cap of $46.70 billion, a P/E ratio of 36.79, a P/E/G ratio of 2.20 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a 50-day moving average of $383.88 and a two-hundred day moving average of $285.00. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same period in the prior year, the firm earned $6.27 earnings per share. The business’s revenue for the quarter was up 26.2% compared to the same quarter last year. As a group, analysts anticipate that Humana Inc. will post 9.12 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on HUM shares. Bank of America raised shares of Humana from a “neutral” rating to a “buy” rating and set a $500.00 target price for the company in a research note on Wednesday, July 29th. Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price target on the stock in a research note on Thursday, July 30th. Needham & Company LLC initiated coverage on shares of Humana in a report on Wednesday, May 20th. They issued a “buy” rating on the stock. Jefferies Financial Group raised shares of Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. Finally, UBS Group began coverage on shares of Humana in a report on Thursday, July 30th. They issued a “buy” rating for the company. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $403.91.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.